Who We Are

Built on over 75 years of experience, SK pharmteco is a trusted partner specializing in the manufacture of APIs and intermediates, viral vectors for gene and cell therapies, registered starting materials and analytical services for the pharmaceutical industry worldwide. Our global operations have the capability and capacity to support your needs from development through commercial production.

Our complementary assets and expertise enable us to provide the highest quality services to our customers.

Our Services

SK pharmteco specializes in the commercial and clinical production of APIs, Advanced Intermediates, Registered Starting Materials, Key Building Blocks and Viral Vectors. Our offerings include process R&D, analytical method development and stability, scale-up and optimization, validation and commercial production. Additionally, we offer extensive Adeno-Associated Viral (AAV) and Lentiviral vector development and cGMP production capabilities.

Our global operations include 7 cGMP manufacturing and development facilities across the United States, Korea, Ireland and France. We also operate a dedicated analytical services facility.

SK pharmteco is a leader in operational excellence and continuous improvement. Our highly skilled team delivers innovative solutions utilizing advanced technologies:

We provide PAI and full regulatory support as well as complete confidentiality. We have a strong record of environmental, health, and safety performance. All our plants have been successfully audited by global regulatory agencies including the FDA (US), EMA (Europe), PMDA (Japan), and MFDS (Korea). 

With a strong technology toolbox and ~1,000 m³ (~265,000 gal) of global small-molecule capacity plus a 5,000 m² facility dedicated to large molecules, we have the capability and capacity to support your needs across the full lifecycle.

The most trusted global partner in the manufacture and testing of medicines.
We reliably deliver pharma products that benefit patients and society across the world through manufacturing and technical excellence with a happy workforce committed to Safety, Quality and Innovation.

Global Presence

7 Manufacturing Sites

~1,000 m³ (~265,000 gal) 
Small Molecule Production Capacity
3 US (589 m³), 2 Korea (276 m³), 1 Ireland (97 m³)

5,000 m² Facility for
Large Molecule Manufacturing
1 France (expanding to 10,000 m²)

3 R&D Centers

Ireland, US, Korea

1 Analytical
Services Facility


75+ Years of Experience

1,500+ Highly Skilled
and Talented Workforce

approved by global regulatory agencies



Diazomethane, Azide, Hydrazine, Ozone

Fixed bed, CSTR, PAT

Simulated Moving Bed (SMB), Batch

Up to 4 m(~1,000 gal) scale 

Down to 10 ng/mcontainment 

Schedule II-V Manufacturing  

Schedule I By Request

Crystallization, Micronization 

Our Team

Play Video


CPhI Milan 2021

Attending CPhI? Pop by Stand 2C46 to meet SK pharmteco’s Pedro Couto Rosado Director of Business Development and Yposkesi’s Dr Brian Mullan Head of


Contact Us

For Business Development & Marketing Enquires contact
Scroll to Top